🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the companies hid safety concerns that the drug posed to children's brain development.

This legal action comes thirty days after President Donald Trump promoted an unproven link between using Tylenol - alternatively called paracetamol - throughout gestation and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication recommended for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he said they "misled consumers by making money from suffering and pushing pills without regard for the risks."

The manufacturer states there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These corporations deceived for years, deliberately risking millions to boost earnings," the attorney general, from the Republican party, said.

Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the reliability of paracetamol and the likely effects that could have on the well-being of American women and children."

On its online platform, Kenvue also stated it had "continuously evaluated the applicable studies and there is lacking reliable evidence that indicates a proven link between taking acetaminophen and autism."

Associations representing physicians and healthcare providers concur.

ACOG has declared paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to address discomfort and fever, which can pose serious health risks if not addressed.

"In more than two decades of research on the consumption of paracetamol in pregnancy, not a single reputable study has successfully concluded that the use of paracetamol in any trimester of gestation results in neurodevelopmental disorders in offspring," the organization commented.

The court filing cites recent announcements from the former administration in claiming the drug is reportedly hazardous.

In recent weeks, Trump raised alarms from public health officials when he advised women during pregnancy to "struggle intensely" not to take acetaminophen when ill.

Federal regulators then published an announcement that doctors should think about restricting the consumption of Tylenol, while also stating that "a direct connection" between the medication and autism in minors has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in spring to conduct "extensive scientific investigation" that would determine the origin of autism in a short period.

But experts cautioned that identifying a unique factor of autism - thought by researchers to be the consequence of a intricate combination of inherited and external influences - would not be simple.

Autism is a category of enduring cognitive variation and disability that affects how people perceive and engage with the surroundings, and is recognized using physician assessments.

In his legal document, the attorney general - a Trump ally who is campaigning for US Senate - claims the manufacturer and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism.

The case attempts to require the firms "remove any promotional materials" that states acetaminophen is reliable for women during pregnancy.

This legal action mirrors the complaints of a assembly of parents of children with autism spectrum disorder and ADHD who sued the producers of Tylenol in 2022.

Judicial authorities dismissed the case, declaring studies from the family's specialists was not conclusive.